Increasing hospital admission rates and economic burden for colorectal cancer in Brazil, 1996-2008

Lacerda‐Filho

2014

Arq. Gastroenterol.

-Context -Weight loss and malnutrition are disorders observed in colorectal cancer patients. Objetives -We sought to evaluate the immediate preoperative nutritional status of patients with colorectal cancer. Methods -This is a cross-sectional clinical study conducted at a single center. Sixty-six consecutive patients in preoperative for elective surgical treatment were studied. The clinical history, socio-demographic data and nutritional status of the patients were evaluated using Subjective Global Assessment and objective (anthropometry) methods. The primary outcome measures were nutritional status classification as nourished or malnourished and the relationship between nutritional status and socio-demographic and clinical features. Results -Most of patients exhibited left colon tumors and disease stage II. According to the Subjective Global Assessment, 36.4% of patients were malnourished. Malnutrition ranged from 7.6% to 53% depending on the evaluation method used, with poor correlation to Subjective Global Assessment. The prevalence of malnutrition was significantly greater in females and non-married patients and in those with two or more symptoms of colorectal cancer. Conclusion -More than a third of patients in the immediate preoperative period for colorectal cancer exhibited malnutrition. Therefore, routine nutritional assessment is highly advisable so that appropriate measures may be taken to minimize the potential postoperative complications. HEADINGS -Colorectal neoplasms. Preoperative period. Malnutrition. Nutrition assessment.

Section: No 4 -Out/dez 2014 Arq Gastroenterol 335mentioning

confidence: 99%

IMMEDIATE PREOPERATIVE NUTRITIONAL STATUS OF PATIENTS WITH COLORECTAL CANCER: a warning

Lacerda‐Filho

2014

Arq. Gastroenterol.

“…National estimates of the direct medical costs of CRC were conducted in France, the United States, Canada, Brazil, and Hungary (20,30,31,34,39,66,69) (Table 2). Estimates were for either the entire population with cancer in a given year or for a subset of newly diagnosed patients in a given year over some defined time period, ranging from the first year following cancer diagnosis up to the patient's lifetime.…”

Section: Direct Medical Costs Of Crc Care In Observational Studiesmentioning

confidence: 99%

Economic Studies in Colorectal Cancer: Challenges in Measuring and Comparing Costs

2013

Estimates of the costs associated with cancer care are essential both for assessing burden of disease at the population level and for conducting economic evaluations of interventions to prevent, detect, or treat cancer. Comparisons of cancer costs between health systems and across countries can improve understanding of the economic consequences of different health-care policies and programs. We conducted a structured review of the published literature on colorectal cancer (CRC) costs, including direct medical, direct nonmedical (ie, patient and caregiver time, travel), and productivity losses. We used MEDLINE to identify English language articles published between 2000 and 2010 and found 55 studies. The majority were conducted in the United States (52.7%), followed by France (12.7%), Canada (10.9%), the United Kingdom (9.1%), and other countries (9.1%). Almost 90% of studies estimated direct medical costs, but few studies estimated patient or caregiver time costs or productivity losses associated with CRC. Within a country, we found significant heterogeneity across the studies in populations examined, health-care delivery settings, methods for identifying incident and prevalent patients, types of medical services included, and analyses. Consequently, findings from studies with seemingly the same objective (eg, costs of chemotherapy in year following CRC diagnosis) are difficult to compare. Across countries, aggregate and patient-level estimates vary in so many respects that they are almost impossible to compare. Our findings suggest that valid cost comparisons should be based on studies with explicit standardization of populations, services, measures of costs, and methods with the goal of comparability within or between health systems or countries. Expected increases in CRC prevalence and costs in the future highlight the importance of such studies for informing health-care policy and program planning.

Environ Health Prev Med

“…The objectives of this study were to estimate the social burden of IHD using the cost of illness (COI) method and to predict future changes. The COI method has been widely used since the 1960s after being introduced by Rice et al as a method that can economically evaluate disease burden [ 2 – 12 ]. As the disease was already studied by another group, the results of which were similar to those evaluated above, the calculation method used in this study is similar to that used in our previous studies [ 13 – 19 ].…”

Section: Introductionmentioning

confidence: 99%

Cost of illness of ischemic heart disease in Japan: a time trend and future projections

Gochi

Matsumoto

Amin

et al. 2018

BackgroundIschemic heart disease (IHD/ICD10: I20-I25) is the second leading cause of deaths in Japan and accounts for 40% of deaths due to heart diseases. This study aimed to calculate the economic burden of IHD using the cost of illness (COI) method and to identify key factors that drive the change of the economic burden of IHD.MethodsWe calculated the cost of illness (COI) every 3 years from 1996 to 2014 using governmental statistics. We then predicted the COI for every 3 years starting from 2017 up to 2029 using the fixed and variable model estimations. Only the estimated future population was used as a variable in the fixed model estimation. By contrast, variable model estimation considered the time trend of health-related indicators over the past 18 years. We derived the COI from the sum of direct and indirect costs (morbidity and mortality).ResultsThe past estimation of COI slightly increased from 1493.8 billion yen in 1996 to 1708.3 billion yen in 2014. Future forecasts indicated that it would decrease from 1619.0 billion yen in 2017 to 1220.5 billion yen in 2029.ConclusionThe past estimation showed that the COI of IHD increased; in the mixed model, the COI was predicted to decrease with the continuing trend of health-related indicators. The COI of IHD in the future projection showed that, although the average age of death increased by social aging, the influence of the number of deaths and mortality cost decreased.